◆ Weekly Recap
Records Fall as AI Capex Powers Broad Rally
US equity benchmarks printed fresh all-time highs as Big Tech earnings, defense contract awards, and biotech catalysts overpowered a hotter-than-expected inflation print and a hawkish FOMC minority. The Nasdaq led at +2.6%, the S&P 500 added +1.8%, and the Dow crossed 54,000 for the first time.
⚡ Index Snapshot
Week-over-Week Performance
S&P 500
7,736.52
▲ +1.8% (+136.02)
Nasdaq Composite
26,584.99
▲ +2.6% (+671.10)
Dow Jones Industrial
54,085.88
▲ +1.7% (+907.47)
10-Yr Treasury Yield
4.71%
▲ +5 bps
◆ Executive Summary
The Week in Three Bullets
- Risk-on rally, records set. Eight of 11 S&P sectors closed higher; 26 of 30 Dow components advanced. Nasdaq breadth widened after upside surprises from Microsoft, Amazon, AMD, and Palantir.
- Fed on hold, dissent rising. The FOMC held at 3.50%–3.75% in a 9–3 vote on July 29. Three officials voted to hike as core PCE ticked up to 3.3%. The 10-year yield backed up to 4.71%.
- AI capex confirmed as the market's spine. With ~169 S&P names reporting, 86% beat and blended EPS growth ran +47.4% YoY. Big Tech capex commentary re-priced the semi and hyperscaler complex higher.
🌐 Macro Backdrop
Rates, Inflation, and Policy
🏦 Federal Reserve
The FOMC left the target range at 3.50%–3.75% at its July 29 meeting. The 9–3 dissent — with three members favoring a hike — marks the deepest split of the cycle. Chair-successor Warsh signaled the Fed "won't hesitate to stop inflation," a hawkish shift the bond market has partly discounted.
Market read: Futures still price in a pause through Q4, but the risk of a "hawkish hold turning into a hike" is now non-trivial.
📉 Rates & Inflation
Core PCE accelerated to 3.3% in June, up from 3.0% in December 2025 — the fifth consecutive year above the 2% target. Energy-driven supply shocks remain the marginal driver.
| Instrument | Yield | Δ WoW |
| 2-Yr UST | 4.273% | +4 bps |
| 10-Yr UST | 4.71% | +5 bps |
| 30-Yr UST | 5.249% | +4 bps |
Geopolitics: Crude softened after the White House confirmed cancellation of a planned strike on Iran citing "positive developments" — a modest tailwind for consumer-cyclical margins and a headwind for energy names.
💼 Earnings Season
Q2 2026 Scorecard
The second-busiest week of the season, with 169 S&P 500 companies reporting. Blended results:
| Metric | Value | Read |
| Beat rate (EPS) | 86% | Well above 5-yr avg (~77%) |
| Blended EPS growth YoY | +47.4% | AI-capex tailwind concentrated in mega-caps |
| Reactions | Mixed | MSFT +15.5% single-day record; AAPL, META punished on margins |
Microsoft's Thursday +15.5% move was the largest single-day market-cap increase in history, driven by 17% YoY revenue growth and a 45.1% operating margin.
🤖 Focus Sector — Technology & AI
AI Capex Reality Check
The week's dominant narrative was AI infrastructure spending being validated by revenue — not merely projected. Hyperscaler results silenced the "capex vigilantes" for now, and options positioning rebuilt into the NVDA August 26 print.
| Ticker | Print | Reaction | Note |
| MSFT | Beat | +15.5% | Rev +17% YoY; op margin 45.1%; Azure re-acceleration |
| AMZN | Beat | Higher | AWS growth & ad monetization |
| AAPL | Beat | Lower | Punished on services margin softness |
| META | Mixed | Lower | Capex step-up unnerved buyside |
| PLTR | Aug 3 | Constructive | Rev +81% to $1.81B; DIA contract, NVDA sovereign-AI tie-up |
| AMD | Aug 4 | →$500 zone | Rev ~$11.2B (+46%); Helios/MI400 rollout |
| NVDA | Aug 26 (pending) | Setup | Positioning re-loaded; sovereign-AI & data-center leadership |
QL Signal Read: Mega-cap tech breadth improved, but dispersion within the group widened. Momentum + Options factors remain the highest-conviction inputs into the composite score for the AI complex.
🛡️ Focus Sector — Defense & Aerospace
Record Backlogs, Modernization Cycle
Prime contractors posted record backlogs and raised guidance, reinforcing a multi-year modernization thesis anchored by missile defense, unmanned systems, and hypersonics. The Trillion-dollar defense budget continues to widen the moat for the primes.
| Ticker | Q2 / Recent | Highlight |
| LMT | Reported Jul 23 | Backlog $230B; Q1 FCF turned negative (-$291M) — watch working-capital burn |
| NOC | Reported Jul 21 | $3B missile interceptor acceleration signed Aug 3 |
| RTX | Reported | Record backlog, guidance raised, missile-defense demand |
QL Signal Read: Defense composites are being lifted by Fundamentals (backlog conversion) and Microstructure (institutional accumulation). Near-term risk is FCF slippage as backlog outpaces conversion.
🧬 Focus Sector — Biotech
Catalyst-Rich August Window
Biotech is entering the year's densest catalyst window with three name-specific setups worth monitoring:
| Ticker | Catalyst | Status |
| MRNA | FDA flu vaccine decision Aug 5 | +177% run into the print |
| REGN | Garetosmab BLA action date | -15% YTD; $18.5B cash; $3B buyback authorized |
| VRTX | Q2 results reported | Rev $3.33B (+12% YoY); FY guide raised to $13.1–13.2B; ALYFTREK & CASGEVY driving |
QL Signal Read: Vertex remains the highest-conviction fundamental setup in the group; Regeneron is a value-and-catalyst pair trade; Moderna is a pure event trade — position accordingly against options-implied moves.
📊 Market Internals
Breadth & Volatility
📈 Breadth
Dow components positive26 / 30
S&P sectors positive8 / 11
Underlying toneImproving, still narrow
Stock-selection premiumRising
📉 Volatility Regime
Global volatility remains contained. India VIX closed the week at ~11.99, sub-12 for most sessions — consistent with a low-vol regime domestically as well. Watch for a vol expansion around NVDA's Aug 26 print and the next CPI release.
🔭 Week Ahead
What to Watch
- Macro: Nonfarm payrolls follow-through, CPI setup, Fed-speak calendar; watch the 10-year through 4.75%.
- Earnings: Tail end of the tech complex; consumer-discretionary reads on the tariff/margin narrative.
- Biotech: MRNA FDA decision resolution, REGN pipeline updates.
- Defense: Continued contract announcements around missile defense and space.
- Setup Risk: Dispersion within mega-cap tech — factor rotation possible if breadth stalls.
α QL Positioning Framework
How to Read This Week Through the Engine
Applied to the 5-factor composite:
- Technical & Momentum: Constructive across mega-cap tech, defense primes, and select biotech (VRTX). Overbought risk building in single names post-print.
- Fundamentals: Confirmed by Q2 beats and guidance raises; margin dispersion is the new alpha.
- Options Positioning: Skew normalized after MSFT/AMD/PLTR relief; NVDA gamma re-loading into Aug 26.
- Microstructure: Institutional flows favor defense & hyperscaler-adjacent semis; energy tape thinning on oil weakness.
Important Disclosure: QuantLogix is not a registered investment advisor, broker-dealer, or financial planner. All content, signals, scores, and analysis in this briefing are for informational and educational purposes only and do not constitute financial advice, investment recommendations, or solicitations to buy or sell securities. Past performance does not guarantee future results. Trading involves substantial risk of loss and is not suitable for every investor. Consult a qualified financial advisor before making investment decisions.